Skip to main content
logo
SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.510
+0.010 (0.29%)
Sep 18, 2026, 4:00 PM EDT - Market closed

SAB Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Market Capitalization
3192982691788916133525294263334222303062162340149
Market Cap Growth (YoY)
1088.96%1728.73%2030.60%408.46%255.39%-43.00%-69.84%-44.79%-24.40%-31.60%88.88%113.36%9.27%-32.89%-86.27%-91.25%-79.77%-57.70%27.67%--
Enterprise Value
222197179738910-39-7-10-966303420272046135336146
Last Close Price
3.513.903.833.742.011.751.363.792.703.104.546.886.308.304.405.907.0114.5037.6078.10100.80

Price Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
-----4.14--------------9.19--
PS Ratio
-------26.48-10.2916.0928.338.056.521.751.240.921.422.905.581.97
PB Ratio
1.361.391.181.180.541.360.591.350.680.620.791.112.162.120.910.960.991.683.928.814.25
P/TBV Ratio
1.491.391.181.180.541.360.591.350.680.620.791.112.162.120.910.960.991.683.928.814.25
P/FCF Ratio
---------------------58.58
P/OCF Ratio
--------------------13.08

EV Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
EV/Sales Ratio
-------6.91---29.327.355.331.551.140.601.062.425.511.93
EV/FCF Ratio
---------------------57.28

Financial Efficiency

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Debt / Equity Ratio
0.020.020.030.040.040.530.320.180.120.120.100.100.310.250.220.190.190.160.160.220.19
Debt / FCF Ratio
---------------------2.68
Net Debt / Equity Ratio
-0.45-0.45-0.44-0.60-0.630.06-0.28-0.62-0.70-0.69-0.73-0.880.15-0.15-0.31-0.29-0.08-0.28-0.39-0.64-0.11
Net Debt / EBITDA Ratio
1.421.421.841.982.61-0.020.160.420.550.781.041.48-0.100.110.290.360.100.470.842.07-1.10
Net Debt / FCF Ratio
1.701.701.901.982.79-0.020.190.470.670.861.122.00-0.160.180.470.360.080.470.582.761.54
Asset Turnover
------0.01-0.020.050.020.160.010.050.170.260.400.640.671.12
Quick Ratio
8.938.9311.069.1310.330.541.332.613.464.975.335.230.260.741.011.371.241.631.871.562.00
Current Ratio
9.229.2211.459.4610.500.871.692.983.695.245.655.450.340.821.101.471.301.721.981.902.09
Return on Equity (ROE)
-40.70%-39.86%-42.61%205.30%-242.08%-87.75%-144.99%-99.73%-59.31%-36.51%-252.02%-116.72%-124.77%-106.08%-102.13%-83.56%-48.75%9.88%-125.51%-44.30%
Return on Assets (ROA)
-24.02%-23.73%-22.13%-29.68%-71.30%-65.43%-51.07%-48.88%-38.28%-36.67%-84.05%-41.73%-41.46%-39.55%-38.00%-34.96%-25.84%-22.57%-27.76%-18.94%
Return on Invested Capital (ROIC)
-19.21%-21.40%-26.02%-34.69%-69.36%-85.43%-95.78%-89.90%-71.96%-109.23%-156.48%-31.01%-38.50%-38.21%-31.42%-28.55%-25.23%-31.35%-32.63%-12.07%
Return on Capital Employed (ROCE)
-31.70%-31.70%-24.40%-30.20%-25.00%-215.00%-148.60%-118.50%-115.10%-84.30%-66.70%-52.10%-141.50%-120.90%-102.10%-80.50%-80.20%-57.20%-42.50%-24.50%6.20%

Yields

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Earnings Yield
-6.82%-4.28%-0.15%7.46%21.16%-227.23%-271.33%-97.39%-182.86%-140.93%-95.18%-66.52%-82.56%-69.77%-122.12%-63.04%-74.32%-31.13%-10.88%-5.05%1.91%
FCF Yield
-17.99%-19.26%-19.75%-25.67%-42.44%-189.67%-249.73%-98.89%-154.73%-130.78%-82.53%-39.91%-40.88%-38.77%-73.77%-86.20%-103.41%-36.30%-16.97%-2.64%-1.71%
Buyback Yield / Dilution
-417.54%-758.07%-476.42%-416.56%-740.93%-0.43%-0.54%-37.44%-76.68%-83.55%-83.38%-50.33%-21.79%-17.26%-10.00%-43.06%-65.67%-65.55%-63.21%10.73%56.64%
SEC Filings: 10-K · 10-Q